News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Conference News ACC 2015 DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR Yael L. Maxwell March 15, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News ACC 2014 Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR L.A. McKeown March 29, 2014
News Conference News ACC 2013 PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished Yael L. Maxwell March 11, 2013
News Conference News ACC 2013 German Valve Registry Shows Advantage of Surgery in Lower Risk Patients L.A. McKeown March 11, 2013
News Conference News ACC 2013 PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device L.A. McKeown March 09, 2013
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012